Researchers at Kazan Federal University in Russia are in the process of testing biodegradable plant-based implants that might one day replace artificial prostheses, eliminating the need for repeat surgeries as a patient’s vasculature evolves.

Two days of debate over the safety of paclitaxel-coated and -eluting devices have culminated in a nonbinding recommendation by the FDA to continue sales of such devices for PAD patients, though the agency is also urging regulators to push for better long-term clinical data than is currently available.

The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.

After years of limited success, researchers have found a way to convert type A blood cells into the more universal type O by leveraging human gut bacteria, according to a report in the magazine Science.

Canadian researchers have singled out a peptide known as apelin that could improve survival in CV patients with aortic aneurysms, leading them to dub the molecule the equivalent of insulin for heart disease.

A Wisconsin high schooler is speaking up for stroke awareness after she suffered a stroke of her own during gym class, WAOW reported—an event her doctors said was brought on by her birth control pills.

Arizona-based R3 Stem Cell, LLC is under fire this week after the FDA sent the company an untitled, three-page letter detailing significant shortcomings in their process.

People who take popular heartburn drugs like Prevacid, Prilosec and Nexium are vulnerable to death from cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer, according to new research published in The BMJ.